GWLL

Goldenwell Biotech, Inc. Stock Price

OTCPK:GWLL Community·US$76.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

GWLL Share Price Performance

US$0.77
-0.73 (-48.67%)
US$0.77
-0.73 (-48.67%)
Price US$0.77

GWLL Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with imperfect balance sheet.

4 Risks
0 Rewards

Goldenwell Biotech, Inc. Key Details

US$55.0

Revenue

US$174.8k

Cost of Revenue

-US$174.7k

Gross Profit

US$100.8k

Other Expenses

-US$275.5k

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.0028
-317,696.36%
-500,983.64%
-77.5%
View Full Analysis

About GWLL

Founded
2019
Employees
n/a
CEO
Shuang Liu
WebsiteView website
goldenwellbiotech.com

Goldenwell Biotech, Inc. engages in the nutraceutical and dietary supplements business. It offers JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Solon, Ohio.

Recent GWLL News & Updates

Recent updates

No updates